AzTrials
AzTrials

Unilateral Transfemoral AmputationNCT07049198

Real-time Motion Capture and Visual Feedback for Amputation Gait Training

A study testing Real-time 2D motion capture and visual feedback system gait training and Conventional physical therapy group in people with Unilateral Transfemoral Amputation and Unilateral Knee Disarticulation, run by National Yang Ming Chiao Tung University at 1 site in Taiwan.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

People with transfemoral amputation face challenges such as gait asymmetry, instability, and increased energy consumption due to loss of the knee joint. Because of the loss of proprioceptive feedback from their missing limbs, visual feedback is essential for gait correction. Read more about this study

Who is it for?
Ages 18 to 65 years
What is being tested?
Real-time 2D motion capture and visual feedback system gait training and Conventional physical therapy group
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteTaiwan
Study dates
15 Jul 2025to 31 Jul 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age between 18 and 65 years
  • Individuals with unilateral transfemoral amputation or knee disarticulation
  • Wear a prosthesis for at least 3 hours per day
  • Have been using a prosthesis for more than 6 months
  • Medicare Functional Classification Level (K-level) of 2 or above
  • Able to walk independently for 5 meters without assistive devices
  • No pain caused by poor prosthetic fit
  • Montreal Cognitive Assessment Taiwan Version (MoCA-T) score ≥ 26

Who cannot join

  • Uncontrolled systemic diseases (e.g., diabetes mellitus, hypertension)
  • Cardiopulmonary or cardiovascular diseases (e.g., heart failure, severe asthma)
  • History of neurological conditions that affect movement (e.g., stroke, spinal cord injury, cerebellar injury)
  • Vestibular disorders
  • Severe osteoporosis
  • Other musculoskeletal injuries or open wounds
Show all 9Show fewer
  • Epilepsy
  • Uncorrected visual impairments
  • Congenital limb deficiency

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Taiwan1 site
  • National Yang Ming Chiao Tung University

    Taipei, 112

    Hui-Ting Shih, PT, PhD, +886-921078256, huiting.shih@nycu.edu.tw

Other trials in Taiwan

About this study

Official title: The Effect of a Real-time 2D Motion Capture and Visual Feedback Gait Training Systems on Walking Performance in People With Unilateral Transfemoral Amputation

People with transfemoral amputation face challenges such as gait asymmetry, instability, and increased energy consumption due to loss of the knee joint. Because of the loss of proprioceptive feedback from their missing limbs, visual feedback is essential for gait correction. Additionally, current visual feedback systems lack portability, cost-effectiveness, and they fail to provide precise, intuitive feedback on spatiotemporal parameters, joint angles, and both frontal and sagittal plane information, limiting their effectiveness in correcting gait abnormalities.This study aims to investigate whether gait training using a real-time 2D motion capture and visual feedback gait training system (2DMV) can improve the gait biomechanics and psychosocial functions of people with unilateral transfemoral amputation (uTFA). The 2DMV system analyzes spatiotemporal parameters and joint kinematics during gait and displays the uTFA's image on a screen, providing visual feedback specifically targeting gait abnormalities. This allows individuals with uTFA to intuitively understand the feedback and make real-time gait adjustments. The biomechanical parameters include joint kinematics, gait symmetry, and walking performance.

Being tested
Real-time 2D motion capture and visual feedback system gait training, Conventional physical therapy group

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Real-time 2D motion capture and visual feedback system gait trainingDevice

    The difference between the VF group and the PT group lies in the use of real-time visual feedback during gait training; the VF group receives real-time visual feedback, while the PT group undergoes gait training without visual feedback.

  • Conventional physical therapy groupOther

    Ten minutes of strength training followed by thirty minutes of gait training, during which the 2DMV system is not used to provide visual feedback. During the gait training, the therapist provides gait correction feedback typically used in conventional physical therapy.

Study groups in NCT07049198
Study groupRoleWhat they receive
Real-time 2D motion capture and visual feedback system gait training group (VF)ExperimentalThe VF group, the 2D motion capture and visual feedback training group, received an intervention consisting of 10 minutes of strength training followed by 30 minutes of visual feedback gait training using the 2DMV system.
Receives: Device: Real-time 2D motion capture and visual feedback system gait training
Conventional physical therapy group (PT)Active comparatorThe PT group, the conventional physical therapy group, received an intervention consisting of 10 minutes of strength training followed by 30 minutes of gait training without the use of the 2DMV system for visual feedback. During gait training, the therapist provided standard gait correction feedback typically used in conventional physical therapy.
Receives: Other: Conventional physical therapy group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Step width ratio

    Step width ratio is calculated by dividing step width by pelvis width (step width/pelvis width), and the normal range is between 0.4 to 1.1.

    Measured: The step width ratio will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.

  2. Step length ratio

    Step length ratio is calculated by dividing the step length of the amputated limb by the step length of the non-amputated limb (a value closer to 1 indicate more symmetry, the step length of amputated limb is calculated as the distance between the heel of the non-amputated limb when initial contact and the heel of the amputated limb when initial contact; the step length of non-amputated limb is calculated as the distance between the heel of the amputated limb when initial contact and the heel of the non-amputated limb when initial contact)

    Measured: The step length ratio will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.

  3. Stride time ratio

    Stride time ratio is calculated by dividing the stride time of the amputated limb by the stride time of the non-amputated limb (a value closer to 1 indicates more symmetry, the stride time of the amputated limb is calculated as the time from initial contact of the amputated limb to next initial contact of the same limb; the stride time of the non-amputated limb is calculated as the time from initial contact of the non-amputated limb to next initial contact of the same limb).

    Measured: The stride time ratio will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.

  4. Stance time ratio

    Stance time ratio is calculated by dividing the stance time of the amputated limb by the stance time of the non-amputated limb (a value closer to 1 indicates more symmetry, the stance time is calculated from initial contact to toe off of the same limb).

    Measured: The stance time ratio will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.

  5. Swing time ratio

    Swing time ratio is calculated by dividing the swing time of the amputated limb by the swing time of the non-amputated limb (a value closer to 1 indicates more symmetry, the swing time is calculated from toe off to initial contact of the same limb).

    Measured: The swing time ratio will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.

  6. Hip extension angle

    The hip extension angle is measured in the sagittal plane during terminal stance.

    Measured: The hip extension angle will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.

  7. Hip flexion angle

    The hip flexion angle is measured in the sagittal plane at the maximum angle of hip flexion during the swing phase.

    Measured: The hip flexion angle will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.

  8. Trunk extension and flexion angle

    The trunk extension and flexion angle is measured in the sagittal plane at the initial contact and terminal stance.

    Measured: The trunk extension and flexion angle will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.

  9. Hip adduction and abduction angle

    The hip adduction and abduction angle is measured in the coronal plane at the maximum angle of hip adduction or abduction angle during the swing phase.

    Measured: The hip adduction and abduction angle will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.

  10. Horizontal pelvis tilt angle

    The horizontal pelvis tilt angle is measured in the coronal plane at the maximum pelvis tilt angle during single-leg stance.

    Measured: The horizontal pelvis tilt angle will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.

  11. Trunk lateral flexion angle

    The trunk lateral flexion angle is measured in the coronal plane during midstance.

    Measured: The trunk lateral flexion angle will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.

Secondary outcomes (4)
  1. The Component Timed-Up-and-Go test, cTUG

    The participant will first be instructed to sit on a chair with a backrest. When the assessor says 'go,' the participant will stand up, walk forward, circle around a cone, return to the chair, and sit down, all at a self-selected speed. The assessor will time the duration of the entire process. The timing of the Component Timed-Up-and-Go test will be divided into five components: standing up, walking forward, circling around the cone, walking back to the chair, and sitting down. Time will be measured in seconds.

    Measured: The Component Timed-Up-and-Go test will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.

  2. Gait speed

    Gait speed will be measured by the assessor with a timer. The participant will be instructed to walk 5 meters at a self-selected speed. The first and last 1 meter will serve as the acceleration and deceleration phases, while the gait speed in middle 3 meters will be measured. Time will be measured in seconds.

    Measured: The gait speed will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.

  3. The Activities-specific Balance Confidence Scale, ABC scale

    The Activities-specific Balance Confidence Scale is a self-reported questionnaire used to assess balance confidence. Scores range from 0% to 100%, with higher scores indicating greater confidence. The scale consists of 16 items in total.

    Measured: The Activities-specific Balance Confidence Scale will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.

  4. The National Aeronautics and Space Administration Task Load Index, NASA-TLX

    The National Aeronautics and Space Administration Task Load Index is a self-repoted scale, totally has 6 items, including mental demand, physical demand, temporal demand, performance, effort, and frustration. The score will recorded as 0 to 100, with the higher score indicating higher work load.

    Measured: The National Aeronautics and Space Administration Task Load Index will be measured after the 12th intervention session.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Jul 2025
  2. Study start15 Jul 2025 (estimated)
  3. Primary completion10 Jul 2027 (estimated)
  4. Study completion31 Jul 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07049198
Sponsor's protocol ID
NYCU114067AE
Status last verified
Jul 2025
First submitted
13 May 2025
Last updated
3 Jul 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Real-time 2D motion capture and visual feedback system gait training and Conventional physical therapy group in people with Unilateral Transfemoral Amputation and Unilateral Knee Disarticulation, run by National Yang Ming Chiao Tung University at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 3 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Hui-Ting Shih (+886 921 078 256, huiting.shih@nycu.edu.tw), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Step width ratio (time frame: The step width ratio will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.). The study lists 11 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jul 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in